The PI3K/AKT/mTOR signaling pathway is also a good regulator of cell proliferation and the metastatic process, allowing us to identify whether the pathway was associated with HMH treatment of BC cells (Figure 7B). This evidence concerns the gene AKT1 and breast cancer.